《高乐氏The Clorox Company（CLX）2026财年第一季度业绩报告「NYSE」（英文版）（13页）.pdf》由会员分享，可在线阅读，更多相关《高乐氏The Clorox Company（CLX）2026财年第一季度业绩报告「NYSE」（英文版）（13页）.pdf（13页珍藏版）》请在三个皮匠报告上搜索。

1、 Clorox Reports Q1 Fiscal Year 2026 Results,Updates Outlook Reports sales and earnings decline primarily due to expected impact of ERP transition OAKLAND,Calif.,November 3,2025 The Clorox Company(NYSE:CLX)today reported results for the first quarter of fiscal year 2026,which ended September 30,2025.

2、First-Quarter Fiscal Year 2026 Summary Following is a summary of key results for the first quarter,which reflects the impact from incremental shipments associated with the enterprise resource planning transition in the U.S.(incremental ERP shipments)in the prior fiscal year and the prior divestiture

3、 of the Better Health Vitamins,Minerals and Supplements(VMS)business.All comparisons are with the first quarter of fiscal year 2025 unless otherwise stated.At the end of the fourth quarter of fiscal year 2025,the company shipped about two weeks of inventory ahead of consumption as retailers built up

4、 stock in anticipation of its ERP transition.As retailers drew down on these inventories this quarter,it resulted in year-over-year shipment decline.Net sales decreased 19%to$1.43 billion,primarily driven by lower shipments related to the ERP transition.Organic sales1 decreased 17%,driven mainly by

5、lower volume related to its ERP transition.Gross margin decreased 410 basis points to 41.7%from 45.8%in the year-ago quarter,primarily driven by lower volume and higher manufacturing and logistics costs,partially offset by cost savings.Diluted net earnings per share(diluted EPS)decreased 19%to$0.65

6、from$0.80 in the year-ago quarter,primarily due to lower net sales in the current period and partially offset by the loss relating to the divestiture of the Better Health VMS business in the prior period.Adjusted EPS1 decreased 54%to$0.85 from$1.86 in the year-ago quarter,primarily due to lower net